COLL

Collegium Pharmaceutical Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↑ 5/10
  • Value↑ 7/10
Collegium Pharmaceutical sales and earnings growth
COLL Growth
Neutral
  • Revenue Y/Y↑ 23.62%
  • EPS Y/Y↓ -7.48%
  • FCF Y/Y↑ 61.11%
Collegium Pharmaceutical gross and profit margin trends
COLL Profitability
Great
  • Gross margin ↑ 59.30%
  • EPS margin↓ 8.10%
  • ROIC 5Y↑ 22.17%
Collegium Pharmaceutical net debt vs free cash flow
COLL Risk
Fair
  • Debt / Equity↑ 2.7
  • Debt / FCF↓ 1.7
  • Interest coverage↓ 2.1

Collegium Pharmaceutical stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗